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Special issue on mast cells in inﬂammation☆Mast cells were discovered by Paul Ehrlich more than a century
ago and classically viewed as effector cells in allergic responses.
However, nowadays mast cells are acknowledged as important
regulators of tissue homeostasis and are involved in innate and adap-
tive immune responses. This insight has triggered a considerable
interest into the role of mast cells in non-allergic pathologies.
Therefore, this special issue of BBA not only aims to give an over-
view of the most up-to-date thoughts on the role of mast cells in
(allergic)-inﬂammation (ﬁrst set of reviews) but also brings to-
gether a series of reviews on their role in non-allergic disease
states.
Because phenotype and function of mast cells depend on the pres-
ence of local environmental cues, there is not only a broad range of
disorders where these cells play a role, but their role may also differ
between disorders and, depending on disease status, even be subject
to changes in time within one disease. It is not possible and certainly
not our intention to cover all different aspects within this special mast
cell issue but, even without being complete, the reader will ﬁnd a
range of papers that underscores the above statement on the diversity
of mast cell functioning. Some of these reviews focus on speciﬁc disor-
ders like autism and malaria, others address more general phenomena
like the role of mast cells in tumor angiogenesis, mast cell–nerve inter-
actions and mast cell transcription factors.
Together they not only underline the versatility and importance of
these cells, but also show how mast cell research has come of age
since these cells were ﬁrst described some 130 years ago. Impor-
tantly, the current understanding of this highly intriguing cell type
not merely holds promise for future investigations but also for
mast-cell-directed therapeutic intervention strategies in disorders
other than allergies alone.
We would like to thank all authors and reviewers for their excellent
contributions and the BBA staff for professional support and hope that
this issue can be a stimulating resource for all those interested in mast
cell research.☆ This article is part of a Special Issue entitled: Mast cells in inﬂammation.
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